HUP0300083A2 - Készítmény immunszupresszív szerek alkalmazása által indukált citotoxikus hatások kezelésére és/vagy megelőzésére - Google Patents

Készítmény immunszupresszív szerek alkalmazása által indukált citotoxikus hatások kezelésére és/vagy megelőzésére

Info

Publication number
HUP0300083A2
HUP0300083A2 HU0300083A HUP0300083A HUP0300083A2 HU P0300083 A2 HUP0300083 A2 HU P0300083A2 HU 0300083 A HU0300083 A HU 0300083A HU P0300083 A HUP0300083 A HU P0300083A HU P0300083 A2 HUP0300083 A2 HU P0300083A2
Authority
HU
Hungary
Prior art keywords
prevention
treatment
immunosuppressive agents
composition
cytotoxic effects
Prior art date
Application number
HU0300083A
Other languages
English (en)
Inventor
Claudio Cavazza
Original Assignee
Sigma-Tau Healthscience S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Healthscience S.P.A. filed Critical Sigma-Tau Healthscience S.P.A.
Publication of HUP0300083A2 publication Critical patent/HUP0300083A2/hu
Publication of HUP0300083A3 publication Critical patent/HUP0300083A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A találmány egy készítményre vonatkozik, amely alkalmas exogén,toxikus vagy metabolikus eredetű sejt- és szövetrendellenességekmegelőzésére és/vagy kezelésére és alkalmas ciklosporin A vagy másimmunszupresszív szerek toxikus hatásainak csökkentésére, ahol akészítmény aktív összetevőként, akár kombinációban akár külön-különcsomagolva (a) propinoil-L-karnitint vagy ennek valamelygyógyászatilag elfogadható sóját és (b) egy, a glicin, a szerin, azalanin és az arginin közül vagy ezek keverékei közül választottaminosavat tartalmaz. Ó
HU0300083A 2000-03-02 2001-02-20 Composition for the prevention and/or treatment of the cytotoxic effects induced by the use of immunosuppressive agents HUP0300083A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2000RM000107A IT1316998B1 (it) 2000-03-02 2000-03-02 Composizione per la prevenzione e/o il trattamento degli effetticitotossici indotti dall'uso di agenti immunosoppressori.
PCT/IT2001/000082 WO2001064204A2 (en) 2000-03-02 2001-02-20 Composition for the prevention and/or treatment of the cytotoxic effects induced by the use of immunosuppressive agents

Publications (2)

Publication Number Publication Date
HUP0300083A2 true HUP0300083A2 (hu) 2003-06-28
HUP0300083A3 HUP0300083A3 (en) 2004-07-28

Family

ID=11454493

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0300083A HUP0300083A3 (en) 2000-03-02 2001-02-20 Composition for the prevention and/or treatment of the cytotoxic effects induced by the use of immunosuppressive agents

Country Status (19)

Country Link
US (1) US7897641B2 (hu)
EP (1) EP1267863B1 (hu)
AR (1) AR027963A1 (hu)
AT (1) ATE335476T1 (hu)
AU (2) AU4103101A (hu)
CA (1) CA2400728C (hu)
CY (1) CY1106169T1 (hu)
CZ (1) CZ20022759A3 (hu)
DE (1) DE60122120T2 (hu)
DK (1) DK1267863T3 (hu)
ES (1) ES2269356T3 (hu)
HU (1) HUP0300083A3 (hu)
IT (1) IT1316998B1 (hu)
MX (1) MXPA02008531A (hu)
PL (1) PL202682B1 (hu)
PT (1) PT1267863E (hu)
SK (1) SK11892002A3 (hu)
TN (1) TNSN01032A1 (hu)
WO (1) WO2001064204A2 (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3135281B8 (en) * 2014-04-22 2020-12-23 Ajinomoto Co., Inc. Composition for preventing or improving peripheral neuropathy
CN115469026B (zh) * 2022-07-14 2023-10-20 中日友好医院(中日友好临床医学研究所) 用于检测环孢素a肾毒性相关标志物的检测试剂、试剂盒及其用途

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1120033B (it) * 1979-10-05 1986-03-19 Sigma Tau Ind Farmaceuti Composizione farmaceutica comprendente-carnitina adatta per l'alimentazione parenterale
US5290538A (en) * 1988-12-22 1994-03-01 Skrezek Christian Nephro protective infusion solutions
JPH0662547B2 (ja) * 1989-01-10 1994-08-17 田辺製薬株式会社 グリシン誘導体
IT1248323B (it) * 1991-05-16 1995-01-05 Sigma Tau Ind Farmaceuti Ammidi con amminoacidi naturali di alcanoil l-carnitine quali inibitori della degenerazione neuronale e attivatori dei processi di apprendimento e memorizzazione e per il trattamento del coma e composizioni farmaceutiche comprendenti tali composti
IT1245869B (it) 1991-06-05 1994-10-25 Sigma Tau Ind Farmaceuti Impiego di propionil l-carnitina per il recupero del tono muscolare in soggetti immobilizzati
US5763408A (en) * 1992-06-03 1998-06-09 Fuji Photo Film Co., Ltd. Amino acid derivatives and application thereof
US5607691A (en) * 1992-06-12 1997-03-04 Affymax Technologies N.V. Compositions and methods for enhanced drug delivery
IT1277147B1 (it) * 1995-01-20 1997-11-04 Sigma Tau Ind Farmaceuti Uso della carnitina e i suoi derivati per ridurre gli effetti tossici della ciclosporina-a e di altri farmaci immunosoppressivi.
EP0793962B1 (en) * 1996-03-04 1999-12-08 Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. Medicament containing a carnitine derivative for treating arteriosclerosis obliterans
US6348495B1 (en) * 1996-06-06 2002-02-19 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Method for treating celiac disease
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
IT1291127B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
US5922766A (en) * 1997-07-02 1999-07-13 Acosta; Phyllis J. B. Palatable elemental medical food
IT1302863B1 (it) * 1998-11-13 2000-10-10 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante e preventiva di alterazionitrombotiche e aterosclerotiche comprendente una carnitina ed un
IT1306130B1 (it) * 1999-04-16 2001-05-30 Sigma Tau Healthscience Spa Composizione comprendente una carnitina e glutatione, atta adaumentare l'assorbimento del glutatione sinergizzandone gli effetti.
IT1306173B1 (it) * 1999-07-23 2001-05-30 Sigma Tau Healthscience Spa Composizione per la prevenzione degli affaticamenti muscolari e permigliorare il rendimento energetico muscolare.
IT1306722B1 (it) * 1999-10-08 2001-10-02 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento di disfunzionicircolatorie, comprendente derivati della l-carnitina ed estratti di
IT1307278B1 (it) * 1999-11-18 2001-10-30 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento di disturbi dovutiad un alterato metabolismo dei lipidi, che comprende propionil
IT1317062B1 (it) * 2000-07-14 2003-05-26 Sigma Tau Healthscience Spa Integratore alimentare utile per prevenire le disfunzioni epatiche ebiliari comprendente una alcanoil l-carnitina.
ITRM20010155A1 (it) * 2001-03-23 2002-09-23 Biosalts Srl Sale di creatina ad aumentato valore nutrizionale e terapeutico e composizioni che lo contengono.

Also Published As

Publication number Publication date
CA2400728C (en) 2009-04-28
HUP0300083A3 (en) 2004-07-28
PL358267A1 (en) 2004-08-09
CY1106169T1 (el) 2011-06-08
ATE335476T1 (de) 2006-09-15
ITRM20000107A0 (it) 2000-03-02
AU2001241031B8 (en) 2005-12-01
WO2001064204A3 (en) 2002-03-28
ES2269356T3 (es) 2007-04-01
US7897641B2 (en) 2011-03-01
SK11892002A3 (sk) 2003-02-04
AR027963A1 (es) 2003-04-16
EP1267863A2 (en) 2003-01-02
DE60122120D1 (de) 2006-09-21
DK1267863T3 (da) 2006-12-04
PL202682B1 (pl) 2009-07-31
CZ20022759A3 (cs) 2003-02-12
US20030144354A1 (en) 2003-07-31
PT1267863E (pt) 2006-10-31
ITRM20000107A1 (it) 2001-09-02
AU4103101A (en) 2001-09-12
IT1316998B1 (it) 2003-05-26
TNSN01032A1 (fr) 2005-11-10
DE60122120T2 (de) 2007-02-08
EP1267863B1 (en) 2006-08-09
MXPA02008531A (es) 2003-02-12
AU2001241031B2 (en) 2005-10-27
WO2001064204A2 (en) 2001-09-07
CA2400728A1 (en) 2001-09-07

Similar Documents

Publication Publication Date Title
ATE218582T1 (de) Cyclosporinderivate, deren herstellung und pharmazeutische zusammensetzungen
IL145430A0 (en) N-cyanomethyl amides, processes for the preparation thereof and pharmaceutical compositions containing the same
ATE218580T1 (de) Cyclosporinderivate, deren herstellung und pharmazeutische zusammensetzungen
ATE329608T1 (de) Formulierungen von copolymer 1 (glatirameracetat) zur oralen, nasalen und pulmonalen verabreichung
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
CA2411754A1 (en) 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoic acid and compositions for delivering active agents
HUP0101543A2 (hu) Női szexuális zavarok kezelésére szolgáló gyógyszerkészítmények
JO3404B1 (ar) تركيبة صيدلانية سائلة تحتوي على مشتقات اريثروبويتين
CY1114594T1 (el) Χρηση της [d-meala]3[etval]4-κυκλοσπορινης για την θεραπεια μολυνσης απο ηπατιτιδα c και φαρμακευτικη συνθεση που περιλαμβανει την εν λογω [d-meala]3[etval]4-κυκλοσπορινη
HUP0301892A2 (hu) Szexuális zavarok kezelésére szolgáló gyógyszerkészítmények és előállításuk
HUP0301349A2 (hu) IL-11-tartalmú készítmények
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
ATE311373T1 (de) Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen
HUP0400553A2 (hu) Gyógyászati készítmények
TW200638927A (en) Bambuterol and integrin inhibitor combination
MY131488A (en) Low dose liquid entecavir formulations and use
MXPA03010054A (es) Composiciones que comprenden lopinavir y metodos para aumentar la biodisponibilidad de agentes farmaceuticos.
EP1571155A4 (en) PEPTIDES AND MEDICAL COMPOSITIONS WITH THE SAME
HUP0300083A2 (hu) Készítmény immunszupresszív szerek alkalmazása által indukált citotoxikus hatások kezelésére és/vagy megelőzésére
AU2173101A (en) Use of carboxy compounds such as 2(4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride as anti-inflammatory agents
GEP20043377B (en) Pharmaceutical Complex
DE60217315D1 (de) Pharmazeutische zusammensetzungen von rapamycines
MXPA04005033A (es) Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes.
HUP0402062A2 (hu) Alkanoil-L-karnitin alkalmazása merevedési zavar kezelésére és ezt tartalmazó gyógyszerkészítmények
MY131159A (en) New pharmaceutical compositions containing epinastine and pseudoephedrine

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P., IT

Free format text: FORMER OWNER(S): SIGMA-TAU HEALTHSCIENCE S.P.A., IT

FD9A Lapse of provisional protection due to non-payment of fees